Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 5/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | NGLY1 | Q96IV0 | 1/20 | 1.00 |
| ▸ | GBA2 | Q9HCG7 | 1/20 | 1.00 |
| ▸ | GBA1 | P04062 | 1/20 | 1.00 |
| ▸ | GANAB | Q14697 | 1/20 | 1.00 |
| ▸ | MAN2B1 | O00754 | 1/20 | 0.65 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.31 |
| ▸ | MGAM | O43451 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Castanospermine SCHEMBL29356587 | 1.00 | GAA (1.00) | GAAMEN1CYP1A2CYP2C9CYP2C19 | |
| Castanospermine SCHEMBL10471084 | 1.00 | GAA (1.00) | GAAMEN1CYP1A2CYP2C9CYP2C19 | |
| Castanospermine SCHEMBL30094437 | 1.00 | GAA (1.00) | GAAMEN1CYP1A2CYP2C9CYP2C19 | |
| Castanospermine SCHEMBL31666834 | 1.00 | GAA (1.00) | GAAMEN1CYP1A2CYP2C9CYP2C19 | |
| Castanospermine SCHEMBL23845877 | 1.00 | GAA (1.00) | GAAMEN1CYP1A2CYP2C9CYP2C19 | |
| Castanospermine SCHEMBL2434193 | 1.00 | GAA (1.00) | GAAMEN1CYP1A2CYP2C9CYP2C19 | |
| Castanospermine SCHEMBL23689596 | 1.00 | GAA (1.00) | GAAMEN1CYP1A2CYP2C9CYP2C19 | |
| Castanospermine SCHEMBL4645261 | 1.00 | GAA (1.00) | GAAMEN1CYP1A2CYP2C9CYP2C19 | |
| Castanospermine SCHEMBL764545 | 1.00 | GAA (1.00) | GAAMEN1CYP1A2CYP2C9CYP2C19 | |
| Castanospermine SCHEMBL13666292 | 1.00 | GAA (1.00) | GAAMEN1CYP1A2CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 11130 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260116861-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-04-30 | — | — | US | claimed |
| US-12569473-B2 | Methods to treat respiratory infection utilizing castanospermine analogs | 60 DEGREES PHARMACEUTICALS, INC. (US) | 2026-03-10 | — | — | US | claimed |
| US-12522572-B2 | Isoxazole hydroxamic acids as histone deacetylase 6 inhibitors | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-01-13 | — | — | US | claimed |
| US-20250295638-A1 | METHODS OF TREATING ALLOGRAFT REJECTION | BARGENT THERAPEUTICS PTY LTD (AU) | 2025-09-25 | — | — | US | claimed |
| US-20250275993-A1 | GLYCOSYLATION INHIBITORS AS THERAPEUTICS FOR STROKE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2025-09-04 | — | — | US | claimed |
| EP-4551215-A1 | METHODS TO TREAT RESPIRATORY INFECTION UTILIZING CASTANOSPERMINE ANALOGS | 60 Degrees Pharmaceuticals LLC (US) | 2025-05-14 | — | — | EP | claimed |
| US-20250114386-A1 | COMBINATION OF A GLYCOSYLATION INHIBITOR WITH ONE CAR CELL THERAPY FOR TREATING CANCER | OSPEDALE SAN RAFFAELE S.R.L. (IT) | 2025-04-10 | — | — | US | claimed |
| EP-4518857-A1 | METHODS OF TREATING ALLOGRAFT REJECTION | Bargent Therapeutics Pty Limited (AU) | 2025-03-12 | — | — | EP | claimed |
| CN-119546301-A | Methods of treating respiratory tract infections using castanospermine analogs | 60度制药有限责任公司 | 2025-02-28 | — | — | CN | claimed |
| EP-4511118-A2 | GLYCOSYLATION INHIBITORS AS THERAPEUTICS FOR STROKE | The Regents of the University of California (US) | 2025-02-26 | — | — | EP | claimed |
| CN-1030418-A | Setaria-semen glycines spermine ester and glycoside | MERRELL DOW PHARMA (US) | 1989-01-18 | — | — | CN | claimed |
| EP-0297534-A2 | Castanospermine esters and glycosides | MERRELL DOW PHARMACEUTICALS INC. (US) | 1989-01-04 | — | — | EP | claimed |
| EP-0295538-A2 | Inhibitors of glycoprotein processing having anti retroviral activity | MERRELL DOW PHARMACEUTICALS INC. (US) | 1988-12-21 | — | — | EP | claimed |
| US-4792558-A | TREATMENT FOR BREAST, LUNG, SKIN, PROSTRATE CANCERS | MERRELL DOW PHARMACEUTICALS INC. (US) | 1988-12-20 | — | — | US | claimed |
| EP-0286224-A2 | Treatment of human viral infection by dsRNA combined with viral inhibitors | HEM PHARMACEUTICALS CORP. (US) | 1988-10-12 | — | — | EP | claimed |
| EP-0272253-A1 | METHOD FOR ENHANCING GLYCOPROTEIN STABILITY | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1988-06-29 | — | — | EP | claimed |
| EP-0252962-A1 | REGULATING RETROVIRAL REPLICATION, INFECTION, AND PATHOGENESIS. | HUTCHINSON FRED CANCER RES (US) | 1988-01-20 | — | — | EP | claimed |
| WO-1987005330-A1 | METHOD FOR ENHANCING GLYCOPROTEIN STABILITY | BERGH MICHEL LOUIS EUGENE | 1987-09-11 | — | — | WO | claimed |
| WO-1987003903-A1 | REGULATING RETROVIRAL REPLICATION, INFECTION, AND PATHOGENESIS | FRED HUTCHINSON CANCER RESEARCH CENTER (US) | 1987-07-02 | — | — | WO | claimed |
| EP-0202661-A2 | Isolation of castanospermine and its use as an antidiabetic agent | MERRELL DOW PHARMACEUTICALS INC. (US) | 1986-11-26 | — | — | EP | claimed |